Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug trials
Pembrolizumab 438
Sodium Chloride 402
Carboplatin 327
Cisplatin 273
Paclitaxel 242
Fluorouracil 223
Oxaliplatin 215
Nivolumab 203
Dexamethasone 201
Rituximab 186
Cyclophosphamide 183
Durvalumab 156
Bevacizumab 156
Paracetamol 155
Capecitabine 151
Atezolizumab 145
Prednisone 125
Docetaxel 125
Tocilizumab 120
Prednisolone 116
Mycophenolate Mofetil 112
Etoposide 112
Gemcitabine 111
Venetoclax 111
Pemetrexed 108
Doxorubicin Hydrochloride 104
Lenalidomide 97
Infliximab 94
Ipilimumab 88
Folinic Acid 86
Acetylsalicylic Acid 85
Semaglutide 84
Placebo 82
Methotrexate 77
Cytarabine 77
Daratumumab 77
Fludarabine Phosphate 75
Letrozole 73
Calcium Folinate 72
Bortezomib 70
Olaparib 69
Gemcitabine Hydrochloride 68
Dapagliflozin 67
Obinutuzumab 66
Azacitidine 65
Trastuzumab 63
Cetuximab 61
Tacrolimus 61
Methylprednisolone 61
Fulvestrant 61
Lenvatinib 60
Irinotecan Hydrochloride Trihydrate 58
Vincristine Sulfate 57
Irinotecan 56
Temozolomide 54
Cemiplimab 54
Trastuzumab Deruxtecan 53
Enzalutamide 51
Dexamethasone Sodium Phosphate 50
Betamethasone Sodium Phosphate 48
Exemestane 48
Apixaban 48
Codeine Phosphate 48
Anastrozole 47
Hydrocortisone 46
Potassium Chloride 46
Empagliflozin 46
Lidocaine Hydrochloride 45
Ribociclib 45
Adalimumab 43
Abemaciclib 43
Doxorubicin 43
Amoxicillin 42
Clopidogrel 42
Pertuzumab 41
Ruxolitinib 41
Tenofovir Alafenamide 40
Rivaroxaban 40
Pomalidomide 40
Ropivacaine Hydrochloride 39
Ibrutinib 39
Oxygen 39
Propofol 39
Pemetrexed Disodium 39
Palbociclib 38
Metformin Hydrochloride 38
Ifosfamide 38
Carfilzomib 37
Dostarlimab 37
Cyclophosphamide Monohydrate 37
Bendamustine Hydrochloride 37
Clavulanic Acid 37
Sulfamethoxazole 36
Osimertinib 36
Trimethoprim 36
Isatuximab 36
Emtricitabine 36
Dexamethasone Phosphate 36
Acalabrutinib 36
Tremelimumab 35

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 VMX-C001

Clinical trials are studying VMX-C001 in people who take a Factor Xa direct oral anticoagulant and need urgent surgery or another high-bleeding-risk procedure.

1 day ago
#2 LIPASE

Clinical trials are investigating LIPASE, including a new lipase product compared with pancrelipase.

1 day ago
#3 TRIACYLGLYCEROL LIPASE

Clinical trials of TRIACYLGLYCEROL LIPASE are studying a new lipase treatment in adults with exocrine pancreatic insufficiency.

1 day ago
#4 IMA401

Clinical trials are investigating IMA401 in patients with recurrent and/or refractory solid tumors.

1 day ago
#5 ALLERGEN EXTRACTS

Clinical trials are studying BLOMIA TROPICALIS POLYMERIZED EXTRACT as part of a vaccine for dust mite and Blomia tropicalis allergy.

1 day ago
#6 AUR200

Clinical trials are investigating AUR200 in people with generalized myasthenia gravis.

1 day ago

Drugs starting by q

  • Quarz Dil. D9 Oleos. (Hab, Vs. 8A Und 12J In Raffiniertem Erdnussöl)

    ,
  • 10 

    Quavonlimab

    ,

    Quavonlimab is an investigational drug being studied in clinical trials for the treatment of advanced solid tumors, including non-small cell lung cancer (NSCLC). These trials are exploring how Quavonlimab works in combination with other cancer drugs, particularly pembrolizumab, to potentially improve outcomes for patients with advanced cancers. The studies are evaluating the safety, effectiveness, and optimal dosing of these drug combinations in different patient groups.

  • Quc398

    ,

    A groundbreaking clinical trial is underway to investigate the potential benefits of QUC398, a new drug designed to address knee osteoarthritis. This study aims to evaluate the drug’s effectiveness in reducing pain, preserving cartilage, and improving overall knee function in patients suffering from this common joint condition. The trial’s results could pave the way for a novel treatment option for those struggling with knee osteoarthritis.

  • Quemliclustat

    ,

    This article explores the use of Quemliclustat, an innovative drug, in various clinical trials for cancer treatment. Quemliclustat, also known as AB680, is being studied in combination with other drugs and therapies to potentially enhance the body’s immune response against different types of cancer. These trials aim to evaluate the safety, efficacy, and potential benefits of Quemliclustat in treating advanced cancers, including pancreatic, prostate, and gastrointestinal malignancies.

  • Quercetin

    , , ,

    Quercetin, a naturally occurring flavonoid found in various plants and fruits, has been the subject of numerous clinical trials investigating its potential therapeutic effects. These studies have explored quercetin’s role in treating a wide range of conditions, including gastroesophageal reflux disease (GERD), chronic obstructive pulmonary disease (COPD), coronary artery disease, post-operative pain, and even COVID-19. This article summarizes the key findings from recent clinical trials, highlighting the promising applications of quercetin in medical research.

  • Quercus Ilex Allergen Extract

    ,

    This article discusses a clinical trial investigating the use of Quercus Ilex (Holm Oak) allergen extract in diagnosing oak pollen allergy. The study aims to determine the optimal concentration of the extract that produces a skin reaction equivalent to a standard histamine solution, potentially improving the accuracy of allergy testing for patients with oak pollen sensitivities.

  • Quercus Robur Pollen Extract

    ,

    This article discusses a clinical trial investigating the use of Quercus Robur (Oak) Pollen Extract in diagnosing oak pollen allergies. The study aims to determine the effectiveness of this extract in skin prick tests, which are commonly used to identify allergies. This research is important for improving the accuracy of oak pollen allergy diagnoses and potentially enhancing treatment options for those affected.

  • Quetiapine

    ,

    Quetiapine, also known by its brand name Seroquel, is an antipsychotic medication that has been studied in various clinical trials for its potential benefits in treating different mental health conditions. These trials have explored its use in schizophrenia, bipolar disorder, major depressive disorder, and other psychiatric conditions. The studies have examined different formulations, dosages, and patient populations to better understand quetiapine’s effectiveness, safety profile, and optimal use in clinical practice.

  • Quinapril Hydrochloride

    , ,

    This article explores the use of Quinapril Hydrochloride in clinical trials for treating hypertension (high blood pressure) and improving cardiovascular health. Quinapril Hydrochloride is a medication that belongs to a class of drugs called ACE inhibitors, which help relax blood vessels and lower blood pressure. We’ll examine various studies that have investigated the efficacy, safety, and potential benefits of Quinapril Hydrochloride, both alone and in combination with other medications, for patients with mild to moderate hypertension and related conditions.

  • Quinidine Sulfate

    ,

    Quinidine sulfate, a medication primarily known for its antiarrhythmic properties, has been the subject of several clinical trials exploring its potential uses in various medical conditions. These trials aim to investigate the drug’s efficacy, safety, and interactions with other medications. The studies cover a range of applications, from treating heart rhythm disorders to potential benefits in neurological conditions and drug interactions.

  • Quinine Dihydrochloride

    This article discusses the use of Quinine Dihydrochloride in clinical trials for Parkinson’s Disease (PD). While the primary focus of the trial is on another drug called Fasudil, Quinine Dihydrochloride is mentioned as a comparator or reference drug. The study aims to evaluate the safety, tolerability, and potential efficacy of these medications in managing PD symptoms.

  • Quizartinib Dihydrochloride

    , ,

    Quizartinib Dihydrochloride, also known as Quizartinib, is a drug currently being studied in clinical trials for the treatment of acute myeloid leukemia (AML), particularly in patients with FLT3-ITD mutations. This article explores the ongoing research and potential benefits of Quizartinib in treating this aggressive form of blood cancer.